DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zerit (Stavudine) - Adverse Event Reports - Disability

 



Index of reports > Cases resulting in disability (23)

     Pulmonary Hypertension (5)Drug Eruption (3)Hyperlactacidaemia (3)Coronary Artery Disease (3)Glucose Tolerance Impaired (3)Cardiomegaly (3)Osteonecrosis (3)Palpitations (3)Nose Deformity (2)Platelet Count Decreased (2)

Below is the selection of adverse event reports related to Zerit (Stavudine) that includes cases resulting in disability.

Adverse event in 46 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-15

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Coronary Artery Disease

Adverse event resulted in: disablity

Suspect drug(s):
Zerit
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Invirase
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Combivir
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Kaletra
    Indication: HIV Infection
    Start date: 2005-01-31

Trizivir
    Indication: HIV Infection
    Start date: 2005-09-21

Norvir
    Indication: HIV Infection
    Start date: 2006-01-11



Adverse event in 46 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-09

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Coronary Artery Disease

Adverse event resulted in: disablity

Suspect drug(s):
Zerit
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Invirase
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Combivir
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Kaletra
    Indication: HIV Infection
    Start date: 2005-01-31

Trizivir
    Indication: HIV Infection
    Start date: 2005-09-21

Norvir
    Indication: HIV Infection
    Start date: 2006-01-11



Adverse event in 46 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-09

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Coronary Artery Disease

Adverse event resulted in: disablity

Suspect drug(s):
Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Trizivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-09-21

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-11

Norvir
    Administration route: Oral
    Start date: 1998-12-30
    End date: 2004-10-25

Other drugs received by patient: Zelitrex; Escitalopram; Seresta



Adverse event in 46 year old male receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from France on 2007-10-01

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Cardiac Disorder

Adverse event resulted in: disablity

Suspect drug(s):
Trizivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-09-21

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Norvir
    Dosage: 100mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-11

Kaletra
    Dosage: 4tab twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31

Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Other drugs received by patient: Zelitrex; Escitalopram; Seresta



Adverse event in 49 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-07-06

Patient: 49 year old male

Adverse reactions / side effects: Renal Failure, Renal Disorder, Diabetes Mellitus, Nephrogenic Anaemia, Hypertension, Nephropathy

Adverse event resulted in: disablity

Suspect drug(s):
Lamivudine
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1997-04-24
    End date: 1999-10-31

Lamivudine
    Administration route: Oral
    Start date: 1999-11-01
    End date: 2003-03-31

Lamivudine
    Dosage: 150mg twice per day
    Administration route: Oral
    Start date: 2003-04-01
    End date: 2005-11-28

Lamivudine
    Administration route: Oral
    Start date: 2007-01-11

Zerit
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1998-03-05
    End date: 2004-01-26

Crixivan
    Dosage: 800mg three times per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1996-07-25
    End date: 1998-12-23

Viracept
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1998-12-24
    End date: 2000-10-18

Other drugs received by patient: Ziagen; Ziagen; Ziagen; Stocrin; Stocrin; Baktar; Zantac; Urinorm; Urinorm; Novact M; Epzicom



Adverse event in 49 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-05

Patient: 49 year old male

Adverse reactions / side effects: Diabetes Mellitus

Adverse event resulted in: disablity

Suspect drug(s):
Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-03-05
    End date: 2004-01-26

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-11-01
    End date: 2005-11-28

Other drugs received by patient: Viracept; Novact M; Baktar; Crixivan; Zantac; Urinorm



Adverse event in male receiving Zerit (Stavudine)

Reported by a individual with unspecified qualification from Japan on 2007-07-02

Patient: male

Adverse reactions / side effects: Hyperbilirubinaemia, Lipoatrophy, Lipodystrophy Acquired, Hepatic Cirrhosis

Adverse event resulted in: disablity

Suspect drug(s):
Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-10-17

Videx EC
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-05-16
    End date: 2003-10-16

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-11-01
    End date: 2003-10-16

Zerit
    Administration route: Oral
    Start date: 1997-10-18
    End date: 1999-10-31

Ziagen
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-04-03

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-16

Stocrin
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-04-03
    End date: 2003-10-16

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-16

Other drugs received by patient: Kaletra; Novact M



Adverse event in 24 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-06-22

Patient: 24 year old male

Adverse reactions / side effects: Pulmonary Hypertension

Adverse event resulted in: disablity

Suspect drug(s):
Saquinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-03-18

Saquinavir
    Administration route: Oral
    Start date: 2000-05-24
    End date: 2000-12-24

Crixivan
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-18
    End date: 2000-05-24

Videx
    Dosage: dose form: oral formulation (not otherwise specified).
    Administration route: Oral
    Indication: HIV Infection

Videx
    Administration route: Oral

Zerit
    Administration route: Oral
    Indication: HIV Infection
    End date: 1998-11-09

Zerit
    Administration route: Oral
    Start date: 1998-11-09
    End date: 1999-06-19

Zerit
    Administration route: Oral
    Start date: 2000-12-25
    End date: 2001-10-20

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-12-24

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25

Stocrin
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Stocrin
    Dosage: the drug was interrupted from 02 oct 2000 to 24 jul 2001
    Administration route: Oral
    Start date: 2000-09-25
    End date: 2000-10-02

Other drugs received by patient: Ziagen; Crosseight M



Adverse event in 24 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-06-11

Patient: 24 year old male

Adverse reactions / side effects: Pulmonary Hypertension, Cardiomegaly

Adverse event resulted in: disablity

Suspect drug(s):
Saquinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-11-01
    End date: 2000-03-18

Saquinavir
    Administration route: Oral
    Start date: 2000-05-24
    End date: 2000-12-24

Crixivan
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2000-03-18
    End date: 2000-05-24

Videx
    Dosage: dose form: oral formulation (not otherwise specified).
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1999-11-01

Zerit
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2000-12-25
    End date: 2001-10-20

Norvir
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 1999-11-01
    End date: 2000-12-24

Kaletra
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2000-12-25

Other drugs received by patient: Stocrin; Ziagen; Crosseight M



Adverse event in 24 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-08

Patient: 24 year old male

Adverse reactions / side effects: Pulmonary Hypertension, Palpitations, Dizziness

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-11-19

Efavirenz
    Dosage: therapy stopped on 25-jul-2000, restarted on 25-sep-2000.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-10-02

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2001-10-20

Indinivir Sulfate
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-08
    End date: 2000-05-24

Ziagen
    Dosage: therapy stopped on 25-jul-2000, restarted on 20-oct-2001.
    Administration route: Oral
    Start date: 2000-07-24
    End date: 2001-10-27

Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19

Ritonavir
    Dosage: therapy stopped on 24-dec-2000, restarted on 01-apr-2005.
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-12-24

Lopinavir + Ritonavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2004-04-24

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15

Other drugs received by patient: Factor Viii



Adverse event in 24 year old male receiving Zerit (Stavudine)

Reported by a individual with unspecified qualification from Japan on 2007-06-06

Patient: 24 year old male

Adverse reactions / side effects: Pulmonary Hypertension, Palpitations, Cardiomegaly

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Crixivan
    Dosage: 800 mg/daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-18
    End date: 2000-05-24

Efavirenz
    Dosage: 600 mg/daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Efavirenz
    Dosage: 600 mg/daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-09-25
    End date: 2000-10-02

Didanosine
    Dosage: 300 mg/daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-11-01

CAP Stavudine
    Dosage: 80 mg/daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25

TAB (Therapy Unspecified)
    Dosage: 600 mg/daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

CAP Invirase (Saquinavir Mesylate)
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-11-01
    End date: 2000-03-18

CAP Invirase (Saquinavir Mesylate)
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-03-18

CAP Invirase (Saquinavir Mesylate)
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-05-24
    End date: 2000-12-24

Norvir
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 1999-10-31

Norvir
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-11-01
    End date: 2000-12-24

Norvir
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-04-01

Videx
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-12-19
    End date: 1997-03-07

Videx
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-03-08
    End date: 2001-07-21

Videx
    Dosage: 400 mg/daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-22
    End date: 2004-05-14

Ziagen
    Dosage: 600 mg/daily
    Administration route: Oral
    Start date: 2000-07-24
    End date: 2000-07-25

Ziagen
    Dosage: 600 mg/daily
    Administration route: Oral
    Start date: 2001-10-20
    End date: 2001-10-27

Kaletra
    Dosage: 6 dose/daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2004-04-24

Zerit
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-08-25
    End date: 1998-02-27

Zerit
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-02-28
    End date: 1998-08-03

Zerit
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-08-04
    End date: 1998-11-09

Zerit
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-11-10
    End date: 1999-06-19

Zerit
    Dosage: see image
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2001-10-20

Other drugs received by patient: Factor Viii



Adverse event in 23 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-06-05

Patient: 23 year old male

Adverse reactions / side effects: Hyperlactacidaemia, Osteonecrosis, Arthralgia, Joint Dislocation, Gait Disturbance

Adverse event resulted in: disablity

Suspect drug(s):
Ziagen
    Dosage: 300mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-03-29

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1995-10-30

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-01-14

Stocrin
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-03-29
    End date: 2002-03-03

Viracept
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-08-04
    End date: 2002-03-03

Norvir
    Dosage: 400mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-11-11
    End date: 1998-03-11

Kaletra
    Dosage: 6cap per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-04

Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-02-11
    End date: 1998-03-11

Serostim
    Indication: Weight Decreased
    Start date: 2001-04-23
    End date: 2005-06-23

Retrovir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1993-05-15
    End date: 1997-11-11

Other drugs received by patient: Loperamide Hydrochloride; Epivir; Hivid; Prozei; Recombinate; Pegasys; Rebetol



Adverse event in 24 year old male receiving Zerit (Stavudine)

Reported by a physician from Japan on 2007-06-05

Patient: 24 year old male

Adverse reactions / side effects: Pulmonary Hypertension, Dyspnoea, Palpitations, Asthenia, Pulmonary Artery Dilatation, Cardiomegaly

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-15

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-11-01
    End date: 2000-12-24

Norvir
    Administration route: Oral
    Start date: 2004-04-25

Videx EC
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-21
    End date: 2004-05-14

Stocrin
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-07-24
    End date: 2000-07-25

Stocrin
    Administration route: Oral
    Start date: 2000-09-25
    End date: 2000-10-02

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-12-25
    End date: 2004-04-24

Videx
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1994-12-19
    End date: 2001-07-21

Zerit
    Administration route: Oral
    Start date: 1997-08-25
    End date: 2001-10-20

Crixivan
    Dosage: 800mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-18
    End date: 2000-05-24

Invirase
    Dosage: 800mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-06-19
    End date: 2000-12-24

Other drugs received by patient: Reyataz; Viread; Anti-Hemophilic Globulin; Ziagen



Adverse event in 49 year old male receiving Zerit (Stavudine)

Reported by a consumer/non-health professional from United States on 2007-04-30

Patient: 49 year old male, weighing 87.0 kg (191.4 pounds)

Adverse reactions / side effects: Disorientation, Hepatitis, Amnesia, Somnolence, Neuropathy Peripheral, Fatigue, Visual Disturbance, Balance Disorder, Chest Pain, Pancreatitis, Myocardial Infarction, Hypertension

Adverse event resulted in: disablity

Suspect drug(s):
Zerit
    Dosage: therapy start date: 1997 or 1998
    Indication: HIV Infection
    End date: 2003-08-01

Videx
    Dosage: therapy start date: 1997 or 1998
    Indication: HIV Infection

Viracept
    Dosage: therapy start date: 1997 or 1998
    Indication: HIV Infection

Epivir
    Indication: HIV Infection

Viread
    Indication: HIV Infection

Other drugs received by patient: Centrum



Adverse event in male receiving Zerit (Stavudine)

Reported by a individual with unspecified qualification from Japan on 2007-03-30

Patient: male

Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-09-26

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-10-18

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-10-18

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-27
    End date: 2004-10-18

Predonine
    Indication: Drug Eruption
    Start date: 2004-09-23
    End date: 2004-09-26

Other drugs received by patient: Clarithromycin; Baktar



Adverse event in male receiving Zerit (Stavudine)

Reported by a individual with unspecified qualification from Japan on 2007-03-22

Patient: male

Adverse reactions / side effects: Nephritis Interstitial, Nephrotic Syndrome

Adverse event resulted in: disablity

Suspect drug(s):
Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-28
    End date: 2004-01-13

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-28
    End date: 2004-09-24

Kaletra
    Administration route: Oral
    Start date: 2001-10-22
    End date: 2002-03-11

Ziagen
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-10-22
    End date: 2002-03-11

Ziagen
    Administration route: Oral
    Start date: 2002-03-28
    End date: 2004-11-03

Ziagen
    Administration route: Oral
    Start date: 2005-03-18

Diflucan
    Indication: Oral Candidiasis
    Start date: 2002-07-24

Viracept
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-06
    End date: 2001-10-21

Viracept
    Administration route: Oral
    Start date: 2004-09-27
    End date: 2004-11-03

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-06
    End date: 2001-10-21

Epivir
    Administration route: Oral
    Start date: 2004-09-27
    End date: 2004-11-03

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-06
    End date: 2002-03-11

Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-05-10
    End date: 2004-09-14

PEG-Intron
    Dosage: 100 micro g/kg
    Indication: Hepatitis C
    Start date: 2004-12-13
    End date: 2005-01-17

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2004-12-13
    End date: 2005-01-14

Ribavirin
    Administration route: Oral
    Start date: 2005-01-15
    End date: 2005-01-17

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-02-16

Stocrin
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-02-16
    End date: 2005-03-28

Lexiva
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-02-16

Epzicom
    Indication: HIV Infection
    Start date: 2005-02-16
    End date: 2005-03-17

Other drugs received by patient: Loxonin



Adverse event in 23 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-03-20

Patient: 23 year old male, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Cachexia, Hyperlactacidaemia, Osteonecrosis, Platelet Count Decreased

Adverse event resulted in: disablity

Suspect drug(s):
Zerit
    Dosage: 22-oct-2002 decreased to 60 mg daily from 80 mg daily.
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1998-01-14
    End date: 2004-05-27

Videx
    Dosage: 150 mg bid 10/30/95, 100 mg bid 12/25/95, 150 mg bid 3/11/98, 200 mg bid 7/12/99-4/20/01
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1995-10-30

Videx
    Dosage: 150 mg bid 10/30/95, 100 mg bid 12/25/95, 150 mg bid 3/11/98, 200 mg bid 7/12/99-4/20/01
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1995-10-30

Videx EC
    Start date: 2001-04-21

Stocrin Caps
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-03-29
    End date: 2002-03-03

Reyataz
    Administration route: Oral
    Start date: 2004-10-08

Viracept
    Dosage: initiated at 500 mg three times daily to 11-nov-1997, restarted 17-aug-1999
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1997-08-04
    End date: 2002-03-03

Ziagen
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-03-29

Kaletra
    Dosage: dosage form=dose
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2002-03-04

Somatropin
    Indication: Weight Decreased
    Start date: 2001-04-23

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-04

Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-11-11
    End date: 1998-03-11

Other drugs received by patient: Lopemin; Recombinate; Amprenavir; Retrovir; Epivir; Hivid; Prozei; Loxonin; Celestone



Adverse event in 23 year old male receiving Zerit (Stavudine)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-03-16

Patient: 23 year old male, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Cachexia, Hyperlactacidaemia, Osteonecrosis, Platelet Count Decreased

Adverse event resulted in: disablity

Suspect drug(s):
Zerit
    Dosage: 22-oct-2002 decreased to 60 mg daily from 80 mg daily.
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1998-01-14
    End date: 2004-05-27

Videx
    Dosage: 150 mg bid 10/30/95, 100 mg bid 12/25/95, 150 mg bid 3/11/98, 200 mg bid 7/12/99-4/20/01
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1995-10-30

Videx
    Dosage: 150 mg bid 10/30/95, 100 mg bid 12/25/95, 150 mg bid 3/11/98, 200 mg bid 7/12/99-4/20/01
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1995-10-30

Videx EC
    Start date: 2001-04-21

Stocrin Caps
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-03-29
    End date: 2002-03-03

Reyataz
    Administration route: Oral
    Start date: 2004-10-08

Viracept
    Dosage: initiated at 500 mg three times daily to 11-nov-1997, restarted 17-aug-1999
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1997-08-04
    End date: 2002-03-03

Ziagen
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1999-03-29

Kaletra
    Dosage: dosage form=dose
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2002-03-04

Somatropin
    Indication: Weight Decreased
    Start date: 2001-04-23

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-03-04

Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1997-11-11
    End date: 1998-03-11

Other drugs received by patient: Lopemin; Recombinate; Amprenavir; Retrovir; Epivir; Hivid; Prozei; Loxonin; Celestone



Adverse event in male receiving Zerit (Stavudine)

Reported by a individual with unspecified qualification from Japan on 2007-03-12

Patient: male

Adverse reactions / side effects: Hyperbilirubinaemia, Lipoatrophy, Lipodystrophy Acquired, Hepatic Cirrhosis

Adverse event resulted in: disablity

Suspect drug(s):
Viread
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-10-17

Videx EC
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-05-16
    End date: 2003-10-16

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-11-01
    End date: 2003-10-16

Zerit
    Administration route: Oral
    Start date: 1997-10-18
    End date: 1999-10-31

Ziagen
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-04-03

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-16

Stocrin
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-04-03
    End date: 2003-10-16

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-01-16

Other drugs received by patient: Kaletra; Novact M



Adverse event in male receiving Zerit (Stavudine)

Reported by a individual with unspecified qualification from Japan on 2007-02-16

Patient: male

Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-09-26

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-10-18

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-10-18

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-27
    End date: 2004-10-18

Predonine
    Indication: Drug Eruption
    Start date: 2004-09-23
    End date: 2004-09-26

Other drugs received by patient: Clarithromycin; Baktar



Adverse event in male receiving Zerit (Stavudine)

Reported by a physician from United States on 2007-02-15

Patient: male

Adverse reactions / side effects: Nose Deformity, Premature Baby, Talipes, Lower Limb Deformity, Pregnancy

Adverse event resulted in: disablity

Suspect drug(s):
Efavirenz
    Indication: HIV Infection
    Start date: 2005-02-23
    End date: 2005-12-29

Zerit
    Start date: 2005-02-23
    End date: 2005-12-29

Epivir
    Start date: 2005-02-23

Viramune
    Start date: 2005-12-29

Retrovir
    Start date: 2005-12-29

Other drugs received by patient: Bactrim; Vitamin B Complex CAP



Adverse event in male receiving Zerit (Stavudine)

Reported by a physician from United States on 2007-02-09

Patient: male

Adverse reactions / side effects: Nose Deformity, Premature Baby, Talipes, Lower Limb Deformity, Pregnancy

Adverse event resulted in: disablity

Suspect drug(s):
Efavirenz
    Indication: HIV Infection
    Start date: 2005-02-23
    End date: 2005-12-29

Zerit
    Start date: 2005-02-23
    End date: 2005-12-29

Epivir
    Start date: 2005-02-23

Viramune
    Start date: 2005-12-29

Retrovir
    Start date: 2005-12-29

Other drugs received by patient: Bactrim; Vitamin B Complex CAP



Adverse event in male receiving Zerit (Stavudine)

Reported by a individual with unspecified qualification from Japan on 2007-01-22

Patient: male

Adverse reactions / side effects: Drug Eruption, Glucose Tolerance Impaired

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-09-26

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-10-18

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-13
    End date: 2004-10-18

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-27
    End date: 2004-10-18

Predonine
    Indication: Drug Eruption
    Start date: 2004-09-23
    End date: 2004-09-26

Other drugs received by patient: Clarithromycin; Bactrim

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009